All the news Showing 10 of 448 articles from: TherapiesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir HIVandhepatitis.com / 06 October 2011 Bristol-Myers Is Close To Completing A Groundbreaking Hepatitis C Treatment Business Insider / 03 October 2011 Vertex takes early rounds of hep C bout with Merck Reuters / 03 October 2011 Updated Hepatitis C Practice Guidelines Now Available from AASLD Market Watch (press release) / 28 September 2011 J&J's hep C drug Incivo approved in Europe InPharm / 22 September 2011 Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes Pharmasset press release / 14 September 2011 Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1 Pharmasset press release / 07 September 2011 Dramatic Changes in Hepatitis C Treatment Expected to Continue Xconomy / 07 September 2011 Vertex Scores Big With Hepatitis Drug Investorplace.com / 01 September 2011 HCV New Drugs Research / 29 August 2011 ← Prev1...3940414243...45Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds